Anakinra in hospitalized patients with severe COVID-19 pneumonia requiring oxygen therapy: Results of a prospective, open-label, interventional study.

International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
A BalkhairO Balkhair

Abstract

The aim of this study was to evaluate the efficacy of anakinra in patients who were admitted to hospital for severe COVID-19 pneumonia requiring oxygen therapy. A prospective, open-label, interventional study in adults hospitalized with severe COVID-19 pneumonia was conducted. Patients in the interventional arm received subcutaneous anakinra (100 mg twice daily for 3 days, followed by 100 mg daily for 7 days) in addition to standard treatment. Main outcomes were the need for mechanical ventilation and in-hospital death. Secondary outcomes included successful weaning from supplemental oxygen and change in inflammatory biomarkers. Outcomes were compared with those of historical controls who had received standard treatment and supportive care. A total of 69 patients were included: 45 treated with anakinra and 24 historical controls. A need for mechanical ventilation occurred in 14 (31%) of the anakinra-treated group and 18 (75%) of the historical cohort (p < 0.001). In-hospital death occurred in 13 (29%) of the anakinra-treated group and 11 (46%) of the historical cohort (p = 0.082). Successful weaning from supplemental oxygen to ambient air was attained in 25 (63%) of the anakinra-treated group compared with 6 (27%) of the histor...Continue Reading

References

Nov 22, 2018·Frontiers in Pharmacology·Giulio Cavalli, Charles A Dinarello
Mar 14, 2020·JAMA : the Journal of the American Medical Association·Giacomo GrasselliMaurizio Cecconi
Mar 21, 2020·Lancet·Puja MehtaUNKNOWN HLH Across Speciality Collaboration, UK
Apr 1, 2020·The Lancet Infectious Diseases·Gavin M Joynt, William Kk Wu
Apr 30, 2020·Nature Reviews. Immunology·Matthew Zirui TayLisa F P Ng
May 4, 2020·Cell Host & Microbe·Eugenia Ziying OngJenny Guek Hong Low
May 5, 2020·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Hasan K Siddiqi, Mandeep R Mehra
May 8, 2020·Annals of the Rheumatic Diseases·Achille AoubaAurélien Justet
May 14, 2020·Nature Medicine·Mingfeng LiaoZheng Zhang
May 15, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Veronica BordoniChiara Agrati
May 22, 2020·The Journal of Allergy and Clinical Immunology·Emanuele PontaliMarco Gattorno
May 22, 2020·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Andrea BorghesiRoberto Maroldi
Jul 1, 2020·Arthritis & Rheumatology·Iris Navarro-MillánMary K Crow
Jul 8, 2020·EClinicalMedicine·Daniel PanManish Pareek
Jul 20, 2020·Critical Care : the Official Journal of the Critical Care Forum·Frank L van de Veerdonk, Mihai G Netea
Jul 28, 2020·Signal Transduction and Targeted Therapy·Li YangYi Zhang
Aug 10, 2020·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Annette Langer-GouldMichael K Gould
Aug 25, 2020·The Lancet Rheumatology·Thomas HuetGilles Hayem
Aug 30, 2020·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Thibault FioletYahya Mahamat-Saleh

❮ Previous
Next ❯

Citations

Feb 11, 2021·Irish Journal of Medical Science·Joseph WilliamsonClive Kelly
Feb 22, 2021·Rheumatology International·Serdar Can GüvenOrhan Küçükşahin
Mar 9, 2021·Frontiers in Medicine·Candice Laverne HendricksMichael Sean Pepper
Mar 13, 2021·Frontiers in Pediatrics·Sara Della PaoleraAndrea Taddio
Mar 18, 2021·Immune Network·Erica EspañoJeong-Ki Kim
Feb 17, 2021·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Cristina de la CalleJosé María Aguado
Apr 6, 2021·The Lancet Rheumatology·Christoffer B NissenKaren Schreiber
Apr 25, 2021·Current Rheumatology Reports·Kristin M D'Silva, Zachary S Wallace
May 8, 2021·Journal of Global Health·Yijia DongEvropi Theodoratou
Jun 3, 2021·Pharmaceuticals·Ashli M HeustessPius S Fasinu
Jun 29, 2021·Advanced Drug Delivery Reviews·Danielle BrainNeill J Liptrott
Jul 9, 2021·Signal Transduction and Targeted Therapy·Lan YangYufeng Zhou
Aug 17, 2021·Current Opinion in Rheumatology·Sebastian E SattuiIris Navarro-Millán
Aug 17, 2021·The Lancet Rheumatology·Evdoxia KyriazopoulouUNKNOWN International Collaborative Group for Anakinra in COVID-19

❮ Previous
Next ❯

Clinical Trials Mentioned

ISRCTN74727214

Software Mentioned

OMA
STATA

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Lancet Rheumatology
Omar MaoujoudNadir Zemraoui
The Lancet Rheumatology
Xavier Valette, Damien du Cheyron
The Lancet Rheumatology
Nicolas Martin-SilvaAchille Aouba
The Lancet Rheumatology
Emma J KooistraPeter Pickkers
The Lancet Rheumatology
Laine Marc, Bonello Laurent
© 2021 Meta ULC. All rights reserved